Answers are grounded in this paper and cite their sources.
Case report reveals recurrent metastatic gastrointestinal stromal tumor in a postpartum woman, highlighting the importance of evaluating unexplained abdominal masses.
Background: Gastrointestinal stromal tumors are rare in pregnancy, and typically present in the second trimester present with size-greater-than-dates, abdominal pain, or nonspecific symptoms. Case: A 31-year-old gravida 1 female presented in the postpartum period with weight loss, cachexia, an abdominal mass, and persistent unexplained tachycardia. She was found to have a recurrent metastatic gastrointestinal stromal tumor and pulmonary emboli. She was anticoagulated and treated with neoadjuvant imatinib therapy with excellent initial response. Unfortunately, she died one year later due to complications of her disease and treatment. Conclusion: Malignancy should be considered in a pregnant woman with size-greater-than-dates or with an abdominal mass, especially when associated with unexplained weight loss and a history of a gastrointestinal stromal tumor, as the recurrence rate is high without continued maintenance therapy. Delivery at 35 to 37 weeks is recommended, and involvement of a multidisciplinary team improves outcomes.
No takes yet. Share an insight, caveat, or question.
Shepp et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: